Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
- Interim data from SEAPORT-1, a Phase 1 trial of INZ-701 in patients with end-stage kidney disease receiving hemodialysis, on..
- Interim data from SEAPORT-1, a Phase 1 trial of INZ-701 in patients with end-stage kidney disease receiving hemodialysis, on..
ROUYN-NORANDA, Quebec, May 07, 2024 (GLOBE NEWSWIRE) -- *Radisson Mining Resources Inc. (TSX-V: RDS, OTCQB: RMRDF)..
*Q1 2024 Activities Update*
*LONDON, UK / ACCESSWIRE / May 7, 2024 / *Trident Royalties Plc (*AIM*:*TRR)(OTCQB:TDTRF*),..